Company: JUPGF
Filing Date: 2025-12-08
Form Type: F-1/A
Source: 0001493152-25-026653
Chunk: 158

Company: ATLAS CRITICAL MINERALS Corp
Filing Date: 2025-12-08
Form: F-1/A
Chunk 158
---
You may read and copy any documents that we file with the SEC, including this prospectus and the related exhibits, without charge at the web site maintained by the SEC at www.sec.gov.

Subsidiary Information

Not applicable.

Annual Report to Securities Holders

Not applicable.

| 117 |

<div align='center'>DISCLOSURE
OF COMMISSION POSITION ON INDEMNIFICATION OF SECURITIES ACT LIABILITIES</div>

We have entered into indemnification
agreements with each of our directors, executive officers and other key employees. The indemnification agreements will require us to
indemnify our directors to the fullest extent permitted by Republic of the Marshall Islands law. We have agreed to indemnify each of
our directors and certain officers against certain liabilities, including liabilities under the Securities Act. Insofar as indemnification
for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons pursuant to the
provisions described above, or otherwise, we have been advised that in the opinion of the SEC such indemnification is against public
policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such
liabilities (other than our payment of expenses incurred or paid by our director, officer or controlling person in the successful defense
of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being
registered, we will, unless in the opinion of our counsel the matter has been settled by controlling precedent, submit to a court of
appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act
and will be governed by the final adjudication of such issue.

| 118 |

<div align='center'>SHARES
ELIGIBLE FOR FUTURE SALE</div>

Future sales of substantial
amounts of our common stock in the public market, including shares issued upon the exercise of outstanding options or warrants, or upon
debt conversion, or the anticipation of these sales, could adversely affect market prices prevailing from time to time and could impair
our ability to raise capital through sales of equity securities.

Upon completion of this
offering we estimate that we will have 4,272,353 outstanding shares of our common stock, calculated as of the date of this prospectus,
assuming no further conversions of preferred stock, no exercise of outstanding options or warrants, and no sale of shares reserved for
the underwriters